Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

XARELTO for Atrial fibrillation: Side Effects & Safety Data

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

There are 1,492 adverse event reports in the FDA FAERS database where XARELTO was used for Atrial fibrillation.

Most Reported Side Effects for XARELTO

Side Effect Reports % Deaths Hosp.
Pulmonary embolism 276 7.9% 27 134
Deep vein thrombosis 234 6.7% 7 98
Drug ineffective 199 5.7% 10 98
Gastrointestinal haemorrhage 198 5.7% 38 148
Cerebrovascular accident 180 5.1% 18 92
Haemoglobin decreased 166 4.7% 21 112
Fall 124 3.5% 39 81
Anaemia 123 3.5% 9 88
Haemorrhage 121 3.5% 28 67
Cerebral haemorrhage 110 3.1% 50 80
Thrombosis 106 3.0% 4 36
Dyspnoea 97 2.8% 11 55
Incorrect dose administered 93 2.7% 8 45
Dizziness 91 2.6% 4 37
Epistaxis 90 2.6% 11 52

Other Indications for XARELTO

Cerebrovascular accident prophylaxis (1,433) Product used for unknown indication (683) Deep vein thrombosis (506) Embolism venous (366) Thrombosis prophylaxis (364) Pulmonary embolism (284) Knee arthroplasty (77) Thrombosis (74) Anticoagulant therapy (39) Hip arthroplasty (36)

Other Drugs Used for Atrial fibrillation

RIVAROXABAN (52,584) DABIGATRAN ETEXILATE (20,492) APIXABAN (10,500) AMIODARONE (9,083) WARFARIN (8,680) EDOXABAN (3,855) ASPIRIN (2,993) DOFETILIDE (2,439) PRADAXA (2,325) METOPROLOL (1,542)

Related Pages

XARELTO Full Profile All Atrial fibrillation Drugs XARELTO Demographics XARELTO Timeline